S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NASDAQ:ICUI

ICU Medical Stock Forecast, Price & News

$232.72
-7.35 (-3.06%)
(As of 11/26/2021 04:00 PM ET)
Add
Compare
Today's Range
$232.21
$239.60
50-Day Range
$205.98
$260.00
52-Week Range
$183.39
$282.00
Volume
68,141 shs
Average Volume
143,462 shs
Market Capitalization
$4.94 billion
P/E Ratio
46.17
Dividend Yield
N/A
Beta
0.5
30 days | 90 days | 365 days | Advanced Chart
Receive ICUI News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.


ICU Medical logo

About ICU Medical

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ICUI
CUSIP
44930G10
Employees
7,900
Year Founded
1984

Sales & Book Value

Annual Sales
$1.27 billion
Cash Flow
$10.51 per share
Book Value
$74.86 per share

Profitability

Net Income
$86.87 million
Pretax Margin
10.03%

Debt

Price-To-Earnings

Miscellaneous

Free Float
19,306,000
Market Cap
$4.94 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/03/2021
Today
11/27/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/24/2022

Social Links


MarketRank

Overall MarketRank

2.00 out of 5 stars

Medical Sector

606th out of 1,392 stocks

Surgical & Medical Instruments Industry

66th out of 125 stocks

Analyst Opinion: 2.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -












ICU Medical (NASDAQ:ICUI) Frequently Asked Questions

Is ICU Medical a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ICU Medical stock.
View analyst ratings for ICU Medical
or view top-rated stocks.

How has ICU Medical's stock been impacted by COVID-19 (Coronavirus)?

ICU Medical's stock was trading at $180.56 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ICUI stock has increased by 28.9% and is now trading at $232.72.
View which stocks have been most impacted by COVID-19
.

When is ICU Medical's next earnings date?

ICU Medical is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for ICU Medical
.

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) announced its quarterly earnings data on Wednesday, November, 3rd. The medical instruments supplier reported $2.07 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.57 by $0.50. The medical instruments supplier had revenue of $336.06 million for the quarter, compared to analysts' expectations of $314.20 million. ICU Medical had a net margin of 8.44% and a trailing twelve-month return on equity of 8.72%. During the same period in the previous year, the firm earned $1.61 EPS.
View ICU Medical's earnings history
.

What price target have analysts set for ICUI?

2 analysts have issued 12 month target prices for ICU Medical's shares. Their forecasts range from $280.00 to $286.00. On average, they expect ICU Medical's share price to reach $283.00 in the next year. This suggests a possible upside of 21.6% from the stock's current price.
View analysts' price targets for ICU Medical
or view top-rated stocks among Wall Street analysts.

Who are ICU Medical's key executives?

ICU Medical's management team includes the following people:
  • Vivek Jain, Chairman & Chief Executive Officer
  • Christian Voigtlander, Chief Operating Officer
  • Brian M. Bonnell, Chief Financial Officer & Treasurer
  • Krishna Uppugonduri, VP-Quality, Medical & Regulatory Affairs
  • Virginia Sanzone, Secretary, Vice President & General Counsel (LinkedIn Profile)

What is Vivek Jain's approval rating as ICU Medical's CEO?

81 employees have rated ICU Medical CEO Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among ICU Medical's employees.

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Janus Henderson Group PLC (10.83%), BlackRock Inc. (7.78%), Neuberger Berman Group LLC (1.72%), Dimensional Fund Advisors LP (1.56%), Schroder Investment Management Group (1.27%) and Geode Capital Management LLC (1.22%). Company insiders that own ICU Medical stock include Elisha W Finney, George A Lopez, Robert S Swinney, Scott E Lamb, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends for ICU Medical
.

Which major investors are selling ICU Medical stock?

ICUI stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Eaton Vance Management, Schroder Investment Management Group, American Century Companies Inc., Janus Henderson Group PLC, Eagle Asset Management Inc., BlackRock Inc., and Raymond James & Associates. Company insiders that have sold ICU Medical company stock in the last year include Elisha W Finney, George A Lopez, Robert S Swinney, Virginia Ruth Sanzone, and Vivek Jain.
View insider buying and selling activity for ICU Medical
or view top insider-selling stocks.

Which major investors are buying ICU Medical stock?

ICUI stock was acquired by a variety of institutional investors in the last quarter, including Balyasny Asset Management LLC, Boston Trust Walden Corp, Barclays PLC, WCM Investment Management LLC, Neuberger Berman Group LLC, UBS Group AG, Point72 Asset Management L.P., and Renaissance Technologies LLC.
View insider buying and selling activity for ICU Medical
or or view top insider-buying stocks.

How do I buy shares of ICU Medical?

Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $232.72.

How much money does ICU Medical make?

ICU Medical has a market capitalization of $4.94 billion and generates $1.27 billion in revenue each year. The medical instruments supplier earns $86.87 million in net income (profit) each year or $5.04 on an earnings per share basis.

How many employees does ICU Medical have?

ICU Medical employs 7,900 workers across the globe.

When was ICU Medical founded?

ICU Medical was founded in 1984.

What is ICU Medical's official website?

The official website for ICU Medical is www.icumed.com.

Where are ICU Medical's headquarters?

ICU Medical is headquartered at 951 CALLE AMANECER, SAN CLEMENTE CA, 92763.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The medical instruments supplier can be reached via phone at (949) 366-2183, via email at [email protected], or via fax at 949-366-8368.


This page was last updated on 11/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.